U.S Study Of Novavax COVID Vaccine Continues With 2 More Shots For Volunteers

Study of a promising COVID-19 vaccine by Novavax is continuing in the U.S. and Mexico. Now, clinical trial participants, including me, are rolling up our sleeves for a third shot and then, three weeks later, a fourth.